Free Account Opening + AMC Free Demat
Loading...

Glenmark Life Sciences IPO vs Rolex Rings IPO

Comparision between Glenmark Life Sciences IPO and Rolex Rings IPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Rolex Rings IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Rolex Rings IPO is up to ₹731.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Rolex Rings IPO is ₹900.00 per share.

  Glenmark Life Sciences IPO Rolex Rings IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹695.00 per share ₹880.00 per share
Issue Price (Upper) ₹720.00 per share ₹900.00 per share
Issue Price (Final) ₹720.00 per share ₹900.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 20 shares 16 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,060.00 Cr up to ₹56.00 Cr
OFS Issue Size 63,00,000 shares 75,00,000 shares
OFS Issue Size (Amount) up to ₹453.60 Cr up to ₹675.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,513.60 Cr up to ₹731.00 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while Rolex Rings IPO opens on Jul 28, 2021. The closing date of Glenmark Life Sciences IPO and Rolex Rings IPO is Jul 29, 2021, and Jul 30, 2021, respectively.

  Glenmark Life Sciences IPO Rolex Rings IPO
Anchor Bid Date
Issue Open Jul 27, 2021 Jul 28, 2021
Issue Close Jul 29, 2021 Jul 30, 2021
Basis Of Allotment (Tentative) Aug 03, 2021 Aug 04, 2021
Initiation of Refunds (Tentative) Aug 04, 2021 Aug 05, 2021
Credit of Share (Tentative) Aug 05, 2021 Aug 06, 2021
Listing date (Tentative) Aug 06, 2021 Aug 09, 2021
Anchor Lockin End date 1 Sep 02, 2021 Sep 03, 2021
Anchor Lockin End date 2 Nov 01, 2021 Nov 02, 2021

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to Rolex Rings IPO P/E ratio of .

  Glenmark Life Sciences IPO Rolex Rings IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 7,969.24 6,861.73 7,822.57
Total Revenue 6,197.57 6,753.32 9,112.54
Profit After Tax 869.55 529.41 590.41
Promoter Shareholding (Pre-Issue) 100% 58.99%
Promoter Shareholding (Post-Issue) 82.84% 57.64%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Rolex Rings IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 16,24,444 shares in Rolex Rings IPO.

  Glenmark Life Sciences IPO Rolex Rings IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 42,42,379 shares 16,24,444 shares
NII 32,32,770 shares 12,18,334 shares
RII 75,43,130 shares 28,42,778 shares
Employee 0 shares 0 shares
Others
Total 1,50,18,279 shares 56,85,556 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Rolex Rings IPO subscribed 130.44x.

  Glenmark Life Sciences IPO Rolex Rings IPO
QIB (times) 36.97x 143.58x
NII (times) 122.54x 360.11x
Big NII (times)
Small NII (times)
RII (times) 14.63x 24.49x
Employee (times)
Other (times)
Total (times) 44.17x 130.44x

Comments

Add a public comment...